Home
  • The project
    • Funders
    • Governance
    • Interviews
    • Work Packages
  • Concept & Approach
  • Network
    • Advisors
  • People with Diabetes
  • News & Events
  • Publications
  • January 27, 2023

    Article on Hypo-RESOLVE featured in IHI's Newsroom

    The Hypo-RESOLVE Consortium is proud to announce that on 24th January 2023 an article featuring Hypo-RESOLE was published in the IHI's online Newsroom. The article 'People with diabetes often can’t “f...

  • January 02, 2023

    Fourth Hypo-RESOLVE progress report

    The Hypo-RESOLVE consortium is happy to announce that the EC accepted its 4th progress report covering the achievements of the third year in Hypo-RESOLVE. The Hypo-RESOLVE consortium is proud to repor...

  • December 19, 2022

    The Hypo-RESOLVE consortium sends season's greetings

    The Hypo-RESOLVE consortium sends season’s greetings and best wishes for the new year to everybody contributing to the project or supporting Hypo-RESOLVE by following us either here or on Twitter. Tha...

  • December 02, 2022

    Hypo-RESOLVE Annual Meeting 2022 – first in-person meeting since start of COVID pandemic

    After over two years of online meetings, the Hypo-RESOLVE consortium was finally able to meet in person again. Partner Abbott kindly hosted the consortium on their premises in Wiesbaden/ Delkenheim fr...

  • September 02, 2022

    Hypo-RESOLVE consortium @EASD

    Various Hypo-RESOLVE members will be featuring at the EASD conference taking place in Stockholm from 19-23 September 2022. Take a look at their contributions in this special Hypo-RESOLVE EASD program...

  • June 23, 2022

    Paper on Hypo-METRICS study protocol published

    The Hypo-RESOLVE consortium is proud to announce that a paper has been published on the Hypo-METRICS study protocol in Diabetic Medicine, namely

    Hypo-METRICS: Hypoglycaemia—MEasurement, ThResholds a...

News & Events Archive

Latest Tweets

Follow us on Twitter

  • Intranet
  • Imprint
  • Privacy
  • Contact
EU logo
IMI logo
EFPIA logo
T1D logo
JDRF logo
IDF logo
Helmsley logo

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 777460. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and T1D Exchange, JDRF, International Diabetes Federation (IDF), The Leona M. and Harry B. Helmsley Charitable Trust.